Hypoglycemic effect of semecarpus anacardium in streptozotocin induced diabetic rats

International Journal of Pharmacology

Volumn 6, Issue 4, 2010, Pages 421-429

  Jaya, A ^a   Shanthi, P ^a   Sachdanandam, P ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

C peptide; Glucose tolerance test; Glutamine: Fructose 6 phosphate amidotransferase; Insulin; N acetyl D glucosaminidase; Semecarpoflavonone

Indexed keywords

C PEPTIDE; GLUCOSAMINIDASE; GLUCOSE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; INSULIN; MESSENGER RNA; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SEMECARPUS ANACARDIUM EXTRACT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIA; IMMUNOBLOTTING; MALE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; UPREGULATION; WEIGHT GAIN;

EID: 77955623518     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.435.443     Document Type: Article

References (37)

1. Al-Rasheed, N.M., G.B. Willars and N.J. Brunskrll, 2006. C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells. J. Am. Soc. Nephrol., 17: 986-995.
2. American Diabetes Association, 2006. Diagnosis and classification of diabetes mellitus. Diabetes Care, 29: 43-48.
3. Aravind, S.G., R. Arimboor, M. Rangan, N.S. Madhavan and C. Arumughan, 2008. Semi-preparative HPLC preparation and HPTLC quantification of tetrahydroamentoflavone as marker in Semecarpus Anacardium and its polyherbal formulations. J. Pharma. Bromed. Analysrs, 48: 808-813.
4. Ami, B., R. Kothai and A.J. Christina, 2004. Hypoglycemic and antihyperglycemic effect of Semecarpus Anacardium Linn in normal and streptozotocin-induced diabetic rats. Methods Find Exp. Clin. Pharmacol., 26: 759-762.
5. Auwerx, J., K. Schoonjans, J.C. Fruchart and B. Staels, 1996. Transcriptional control of triglyceride Metabolism: fibrates and fatly acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis, 124: 29-37.
6. Barroso, I., M. Gurnell, V.E. Crowley, M. Agostini and J.W. Schwabe et al., 1999. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, Diabetes mellitus and hypertension. Nature, 402: 880-883.
7. Cohen, P. and M. Goedert, 2004. GSK3 inhibitors: Development and therapeutic potential. Nat. Rev. Drug Discov., 3: 479-487.
8. Daniels, M.C., D.A. McClain and E.D. Crook, 2000. Transcriptional regulation of transforming growth factor betal by glucose: Investigation into the role of the hexosamine biosynthesis pathway. Am. J. Med. Sci., 319: 138-142.
9. Dong, D.L. and G.W. Hart, 1994. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem., 269: 19321-19330.
10. Farook, V.S., C. Bogardus and M. Prochazka, 2002. Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 Diabetes mellitus in Pima Indians. Mol. Genet. Metab., 77: 189-193.
11. Formulary, 1972. Formulary of Siddha Medicine. 2nd Edn, Indian Medicine Practitioners Co-operative Pharmacy and Stores Ltd., Madras, India, pp: 197.
12. Gedam, P.H., P.S. Sampath Kumara and M.A. Sivasamban, 1974. Composition of Bhilawanol from Semecarpus Anacardium Linn. Phytochemistry, 13: 513-515.
13. Jia, R.Y., Z.Q. Yin, X.L. Wu, D.B. Liu and Y.H. Du et al., 2008. Hypoglycemic effect of flavonoids from Prinsepia utilis on alloxan-induced diabetic mice. Zhong Yao Cai., 31: 399-403.
14. Kameswara Rao, B., P. Renuka Sudarshan, M.D. Rajasekar and C. Appa-Rao, 2003. Antidiabetic activity of Terminalia pallida fruit in alloxan induced diabetic rats. J. Ethnopharmacol., 85: 169-172.
15. Kaneto, H., G. Xu, K.H. Song, K. Suzuma, S. Bonner-Weir, A. Sharma and G.C. Weir, 2001. Activation of the hexosamine pathway leads to deterioration of pancreatic a-cell function through the induction of oxidative stress. J. Biol. Chem., 276: 31099-31104.
16. Kothai, R.,B. Arul, K.S. Kumar and A.J. Christina, 2005. Hypoglycemic and antiperglycemic effects of Semecarpus Anacardium linn in normal and alloxan-induced diabetic rats. J. Herb Pharmacother., 5: 49-56.
17. Kurup, P.N.V., V.N.K. Ramdas and P. Joshi, 1979. Hand Book of Medicinal Plants. Oxford and IBM Publishing Co. Pvt. Ltd., New Delhi, pp: 32.
18. Luo, B., G.J. Parker, R.C. Cooksey, Y. Soesanto, M. Evans, D. Jones and D.A. McClain, 2007. Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes. J. Biol. Chem., 282: 7172-7180.
19. Modak, M.A., S.P. Datar, R.R. Bhonde and S.S. Ghaskadbi, 2007. Differential susceptibility of chick and mouse islets to streptozotocin and its co-relation with islet antioxidant status. J. Comp. Physiol., 177: 247-257.
20. Murthy, S.S.N., 1992. New bioflavonoid from Semecarpus Anacardium Linn. Clin. Acta Turcica, 20: 33-37.
21. Nair, P.K., S.J. Melnick, S.F. Wnuk, M. Rapp, E. Escalon and C. Ramachandran, 2009. Isolation and characterization of an anticancer catechol compound from Semecarpus Anacardium. J. Ethnopharmacol., 122: 450-456.
22. Patsouris, D., M. Muller and S. Kersten, 2004. Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. Curr. Opin. Investig. Drugs, 5: 1045-1050.
23. Rai, M. K., A.K. Pandey and D. Achaiya, 2000. Ethno-medicinal plants used by gond tribe of Bhanadehi, District Chhindwara, Madhya Pradesh. J. Non-Timber Forest 7: 237-241.
24. Rakieten. N., B.S. Gordon, D.A. Cooney, R.D. Davis and P.S. Schein, 1968. Renal tumorigenic action of streptozotocin (NSC-85998) in rats. Cancer Chemother. Rep., 52: 563-567.
25. Rao, N.P., L. Ramachandra Rao and R.J. Brown, 1973. Phenolic constituents of Semecarpus anacardium. Phytochemistry, 12: 671-681.
26. Rieusset, J., F. Andreelli, D. Auboeuf, M. Roques, P. Vallier, J.P. Riou, J. Auweix, M. Laville and H. Vidal, 1999. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes, 48: 699-705.
27. Sahoo, A.K., N. Narayanan, S. Sahana, S.S. Rajan and P.K. Mukherjee, 2008. In vitro antioxidant potential of Semecarpus anacardium L. Pharmacol. Online, 3: 327-335.
28. Samnegard, B., S.H. Jacobson, G. Jaremko, B. Johansson and K. Ekberg et al., 2005. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol. Dial. Transpl., 20: 532-538.
29. Selvam, C. and S.M. Jachak, 2004. A cyclooxygenase (COX) inhibitory biflavonoid from the seeds of Semecarpus Anacardium. J. Ethnopharmacol., 95: 209-212.
30. Shin, Y.G., G.A. Cordell, Y. Dong, J.M. Pezzuto, A.V.N. Appa Rao, M. Ramesh, B.R. Kumar and M. Radhakishan, 1999. Rapid identification of cytotoxic alkenyl catechols in Semecarpus Anacardium using bioassay-linked high performance liquid chromatography-electrospray/mass spectrometric analysis. Phytochem. Analysis, 10: 208-212.
31. Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res., 50: 537-546.
32. Toleman, C., A J. Paterson, R. Shin and J.E. Kudlow, 2006. Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog. Biochem. Biophys. Res. Commun., 340: 526-534.
33. Vijayalakshmi, T., V. Muthulakshmi and P. Sachdanandam, 2000. Toxic studies on biochemical parameters carried out in rats with Serankottai nei, a siddha drug-milk extract of Semecarpus anacardium nut. J. Ethnopharmacol., 69: 9-15.
34. Vosseller, K., L. Wells, M.D. Lane and G.W. Hart, 2002. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Nat. Acad. Sci. USA., 99: 5313-5318.
35. Yki-Jarvinen, H., E. Ferrannini, J. Knuuti and P. Nuutila, 2004. Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver. Diabetologia, 47: 1149-1156.
36. Yoon, J.C., P. Puigserver, G. Chen, J. Donovan and Z. Wu et al., 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature, 413: 131-138.
37. Young, P.W., M.A. Cawthorne, P.J. Coyle, J.C. Holder and G.D. Holman et al., 1995. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT 4 as measured by photoaffinity labeling. Diabetes, 44: 1087-1092.